Showing 1 to 10 of 54 Clinical Trials
|
CLINICAL TRIAL Trial No ClinicalTrials.gov ID |
Principal Investigator
Coordinator |
||
|---|---|---|---|
|
Phase I Open-label, Multi-center Study to Evaluate the Safety, Tolerability, Dosimetry, and Preliminary Activity of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
CFXX489A12101 NCT06562192  Recruiting
|
CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL
|
Breast Colon and Rectum Non Small Cells - Lung Pancreas |
Dr. Nicolas Plouznikoff Adeline Hamon 514-890-8000 poste 30737 |
|
Phase I Trial of Camu Camu Prebiotic and Immune Checkpoint Inhibition in Patients With Non-Small Cell Lung Cancer and Melanoma
BR-2021-CamuCamu NCT05303493 Recruiting
|
CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL
|
Melanoma Non Small Cells - Lung |
Dr. Bertrand Routy Wiam Belkaid 514-890-8000 |
|
Phase I Trial of Camu Camu Prebiotic and Immune Checkpoint Inhibition in Patients With Non-Small Cell Lung Cancer and Melanoma
BR-2021-CamuCamu NCT05303493 Recruiting
|
CISSS DE LA MONTEREGIE-CENTRE
HOPITAL CHARLES-LE MOYNE
|
Melanoma Non Small Cells - Lung |
Dr. Nathalie Daaboul Marilyn Tessier 450-466-5000 poste 7691 |
|
A Randomized Phase III Study of Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) in High Risk Patients With Stage I Non-Small Cell Lung Cancer (NSCLC), The STABLE-MATES Trial
STABLE-MATES Trial (JoLT-Ca) NCT02468024 Recruiting
|
CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL
|
Non Small Cells - Lung |
Dr. Édith Filion Dr. Moishe Liberman Adeline Jouquan 514-890-8000 poste 26214 |
|
Study of the function and phenotype of tumor infiltrating lymphocytes in non-small cell lung cancer (Main study)
QC-CAPRION n.d. Recruiting
|
CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL
|
Non Small Cells - Lung |
Dr. Moishe Liberman Adeline Jouquan 514-890-8000 poste 26214 |
|
Stereotactic Ablative Radiotherapy for Oligo-Progressive Disease REfractory to Systemic Therapy in Non Small Cell Lung Cancer: A Registry-based Phase II Randomized Trial
SUPPRESS-NSCLC NCT04405401 Recruiting
|
CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL
|
Non Small Cells - Lung |
Dr. Houda Bahig Diane Trudel 514-890-8000 poste 11181 |
|
A Phase 2 Multicenter Study of Autologous Tumor Infiltrating Lymphocytes (LN-145) in Patients With Metastatic Non-Small-Cell Lung Cancer
IOV-LUN-202 NCT04614103 Recruiting
|
CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL
|
Non Small Cells - Lung |
Dr. Simon Turcotte Adeline Hamon 514-890-8000 poste 30737 |
|
A Phase II Open-label, Multicentre, Randomised Study of Neoadjuvant and Adjuvant Treatment in Patients With Resectable, Early-stage (II to IIIA) Non-small Cell Lung Cancer
NeoCOAST-2 NCT05061550 Recruiting
|
CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL
|
Non Small Cells - Lung |
Dr. Moishe Liberman Adeline Jouquan 514-890-8000 poste 26214 |
|
This is a single-center randomized trial in patients with non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibition. Patients will receive standard-of-care immune checkpoint inhibitor (ICI) therapy alone or in combination with a dietary intervention
2023-11332 NCT05805319 Recruiting
|
CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL
|
Non Small Cells - Lung |
Dr. Bertrand Routy Wiam Belkaid 514-890-8000 |
|
A Phase III, Randomized, Double-blind, Multicenter, Global Study of Rilvegostomig or Pembrolizumab in Combination With Platinum-based Chemotherapy for the First-line Treatment of Patients With Metastatic Non-squamous Non-small Cell Lung Cancer Whose Tumors Express PD-L1
ARTEMIDE-Lung03 NCT06627647 Recruiting
|
CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL
|
Non Small Cells - Lung |
Dr. Normand Blais Chantal Gosselin 514-890-8000 poste 24892 |
Groupe d'étude en oncologie du Québec